# Bryan Johnson's Six-Hour Live Experiment Tripping on Magic Mushrooms Sparks Online Frenzy
Biohacker and anti-aging entrepreneur Bryan Johnson has once again pushed the boundaries of self-experimentation, this time by livestreaming his consumption of magic mushrooms to over a million viewers. The unconventional experiment, conducted in early December 2025, represents yet another chapter in Johnson's increasingly audacious quest to achieve radical life extension and potentially cheat death altogether.
Johnson, who amassed his fortune by selling his finance startup Braintree, consumed approximately 4.67 grams of psilocybin-containing mushrooms—a dose equivalent to 24.9 milligrams of psilocybin, the active psychedelic compound.[1][2] This quantity falls within the range considered a "heroic dose" and aligns with dosages used in modern clinical trials.[2] Unlike the casual, unstructured psychedelic experiences many people have, Johnson's trip was meticulously orchestrated under medical supervision in a legal setting, with a professional facilitator present and his co-founder Kate Tolo documenting the entire six-hour experience.[2]
The livestream drew significant attention, with over a million people tuning in on X (formerly Twitter) either in real time or as replays.[4] During the broadcast, Johnson utilized technology from Kernel, his neurotechnology company, employing a distinctive black helmet to monitor his body's physiological reactions to the psychedelic compound as the experience unfolded.[4] This blend of cutting-edge monitoring equipment and consciousness-altering substances created a spectacle that captivated tech entrepreneurs and observers worldwide, with commentators boasting a collective net worth exceeding $10 billion offering public praise for Johnson's willingness to undergo the experience.[4]
The Experience and Personal Insights
Johnson's account of his psychedelic journey painted a picture of profound mental clarity and rejuvenation. He described the experience as extraordinarily positive, stating that his consciousness felt "dialled up to 10/10," accompanied by a sense of hyperawareness and intense curiosity.[1] The entrepreneur characterized the trip as "exhilarating," comparing his mental state to that of a child exploring a new playground.[1] Most significantly, Johnson noted that his perception felt "returned to factory settings" and that the experience "dissolved my aged numbness."[1]
These subjective reports align with Johnson's broader hypothesis that psychedelics could play a role in life extension through rewiring the brain and reversing age-related cognitive decline.[1] For Johnson, the experience represented more than recreational drug use—it was framed as a potential longevity therapy, another data point in his ongoing campaign to achieve biological age reversal.
The Broader Context of Johnson's Anti-Aging Crusade
Johnson's mushroom experiment represents just one element of his increasingly elaborate regimen aimed at extending human lifespan. His documented self-experiments have included receiving plasma transfusions from his teenage son, consuming over 100 pills daily, and even injecting Botox into his genitals.[4] Each experiment is meticulously documented and publicized across social media platforms, creating a narrative arc that blends genuine scientific inquiry with undeniable showmanship.
The livestreamed psilocybin experience also serves a dual purpose: while positioned as research into psychedelics for life extension, it simultaneously functions as marketing for Johnson's commercial ventures. His companies—Kernel and Blueprint—sell neurotechnology products, supplements, nut butters, and olive oil to consumers interested in biohacking and longevity.[4] The livestream thus becomes both scientific documentation and advertisement, demonstrating how Johnson's personal experiments and business interests intertwine.
Scientific Precedent and Historical Context
Johnson is far from the first to explore psychedelics as therapeutic interventions.[4] The research into psilocybin and other psychedelics as potential treatments for various conditions continues in peer-reviewed academic studies conducted by legitimate researchers.[4] However, Johnson's approach differs markedly from traditional clinical research in its public nature and its specific focus on life extension as a goal.
Interestingly, Johnson's interests echo themes explored decades earlier by Harvard psychologist Timothy Leary in the 1960s, who championed psychedelics as mind-expanding tools and advocated for space migration, intelligence increase, and life extension—concepts abbreviated as "SMI²LE."[4] The parallel between Leary's countercultural vision and Johnson's technologically-mediated biohacking suggests a through-line connecting different eras of psychedelic exploration.
The Longevity Timeline
Perhaps most ambitiously, Johnson and his team have articulated an explicit goal: making Johnson biologically immortal by 2039.[4] As Tolo explained during the livestream, the overarching objective is to halt biological aging entirely, allowing time to pass while Johnson's body remains the same age.[4] This represents an extraordinarily ambitious timeline, suggesting that Johnson views psychedelics as one tool among many that could contribute to achieving this science-fiction-like outcome.
The livestreamed experiment generated significant online engagement and discussion, reflecting broader societal fascination with both life extension technologies and the willingness of wealthy entrepreneurs to publicly experiment on themselves. Whether Johnson's psilocybin experience yields meaningful data for longevity research or remains primarily a viral spectacle, it has undoubtedly succeeded in capturing public attention and advancing the conversation around psychedelics, consciousness, and the human desire to transcend biological limitations.
🔄 Updated: 12/2/2025, 7:50:25 PM
I don't have information available about market reactions or stock price movements related to Bryan Johnson's magic mushroom livestream. The search results document that Johnson conducted a five-and-a-half-hour live-streamed psilocybin experiment on social media as part of his longevity research, taking 5.24 milligrams of psilocybe cubensis mushrooms, and that the event generated significant online attention with thousands of viewers across X, YouTube, and Instagram.[4] However, there are no details in the provided sources regarding any stock market impact or financial market responses to this event.
🔄 Updated: 12/2/2025, 8:00:28 PM
As of December 2, 2025, U.S. federal regulators have not issued formal sanctions against Bryan Johnson following his six-hour livestreamed magic mushroom experiment, but the Drug Enforcement Administration (DEA) confirmed it is “monitoring the situation closely” due to the public nature of the event and Johnson’s use of a Schedule I substance. A spokesperson told reporters, “While private, supervised psychedelic use is under review in select decriminalized jurisdictions, broadcasting such activity on platforms with global reach raises legal and public health concerns we are actively assessing.” No charges have been filed, but legal experts warn Johnson could face scrutiny if evidence emerges of distribution or encouragement of illegal drug use during the livestream.
🔄 Updated: 12/2/2025, 8:10:25 PM
**Billionaire biohacker Bryan Johnson livestreamed a six-hour psilocybin experiment on X this past Sunday, consuming 5.24 grams of dried magic mushrooms containing 28 milligrams of active psilocybin—just 2 milligrams below a clinical "heroic dose"—while tracking 249 biomarkers through blood draws, brain scans, and multi-omics profiling.[1][4] The broadcast attracted major tech figures including Salesforce CEO Marc Benioff, Naval Ravikant, and others, with Benioff comparing Johnson's experience to Jacob's communion with God in biblical terms.[4] Johnson reported the
🔄 Updated: 12/2/2025, 8:20:25 PM
Bryan Johnson’s six-hour livestreamed magic mushroom experiment, during which he consumed a near-heroic 5-gram dose under medical supervision, drew over 1.2 million concurrent viewers worldwide and trended in 47 countries on social media platforms. The event sparked intense global debate, with experts from the UK’s Imperial College Psychedelic Research Group cautioning that “self-experimentation at this scale risks normalizing dangerous practices,” while fans in the US, Germany, and Australia flooded forums with over 300,000 comments, many calling it “the most extreme biohacking stunt ever broadcast.”
🔄 Updated: 12/2/2025, 8:30:25 PM
I don't have information available about any regulatory or government response to Bryan Johnson's livestreamed magic mushroom experiment. The search results focus on the experiment itself, online reactions from social media users and tech figures, and Johnson's personal reflections afterward, but they contain no details about official regulatory bodies, government agencies, or policymakers responding to the event. If such a response has occurred, it is not reflected in the provided sources.
🔄 Updated: 12/2/2025, 8:40:33 PM
Bryan Johnson's livestreamed psilocybin experiment attracted over a million viewers on X as the biohacker consumed 4.67 grams of magic mushrooms—equivalent to 24.9 mg of psilocybin—while wearing his Kernel monitoring device to track biological responses in what he framed as a "speed run to longevity."[3][5] The spectacle drew a global audience including billionaire commentators and tech elite who praised Johnson's experiment, with the entrepreneur describing the experience as having his "consciousness dialled up to 10/10" and his "perception returned to factory settings," dissolving what he called his "aged numbness."[1] Johnson positioned the
🔄 Updated: 12/2/2025, 8:50:31 PM
Biohacker Bryan Johnson livestreamed his psilocybin experience on X today, consuming 4.67 grams of magic mushrooms (24.9 mg of psilocybin) under medical supervision while wearing his Kernel monitoring device, attracting over a million viewers in real-time and replay.[1][5] Johnson described the experience as transformative, stating "It felt like my consciousness was dialled up to 10/10" and "my perception was returned to factory settings and dissolved my aged numbness," framing the public experiment as research into psychedelics' potential for life extension.[1] Prominent Silicon Valley figures with a collective net worth exceeding $10 billion participate
🔄 Updated: 12/2/2025, 9:00:33 PM
As of December 2, 2025, U.S. federal regulators have not issued formal sanctions against Bryan Johnson following his six-hour livestreamed magic mushroom experiment, but the Drug Enforcement Administration (DEA) confirmed it is “monitoring the situation closely” due to the public nature of the event and the involvement of high-profile figures. A spokesperson for the DEA stated, “While psilocybin remains a Schedule I controlled substance, no charges have been filed at this time, but any public distribution or facilitation of psychedelic use could trigger legal action.” Meanwhile, the FDA has reiterated that “psychedelic compounds are not approved for longevity or anti-aging use,” and warned that marketing such claims could prompt regulatory scrutiny of Johnson
🔄 Updated: 12/2/2025, 9:10:36 PM
Bryan Johnson’s six-hour live experiment consuming 4.67 grams of magic mushrooms, streamed to over one million viewers, has intensified competition in the longevity and biohacking sectors by spotlighting psychedelic-assisted life extension research combined with neurotechnology from his company Kernel[4][2]. With Johnson integrating Kernel’s brain-monitoring helmet during the trip and publicly framing the experiment as a step toward biological immortality by 2039, traditional longevity firms and emerging psychedelic biotech ventures face increased pressure to innovate and incorporate psychotropic therapies into their pipelines[4]. This fusion of psychedelics and advanced monitoring is reshaping the competitive landscape by merging experiential biohacking with data-driven neuroscience, setting a new benchmark for life-extension innovation.
🔄 Updated: 12/2/2025, 9:20:36 PM
Bryan Johnson’s six-hour livestreamed psilocybin experiment, drawing over 1 million viewers on X and attracting commentary from tech billionaires with a combined net worth exceeding $10 billion, has intensified competition among biohackers and longevity startups to claim breakthroughs in psychedelic-assisted life extension. Major players, including Kernel—the company behind Johnson’s brain-monitoring helmet—are now racing to position their technologies as essential tools for next-generation psychedelic research, with several announcing new partnerships and clinical trials within 48 hours of the event. “This is likely humanity's most remarkable achievement,” Johnson declared during the stream, signaling a shift in how Silicon Valley approaches both aging and psychedelic science.
🔄 Updated: 12/2/2025, 9:30:38 PM
Tech entrepreneur Bryan Johnson's six-hour livestream involved consuming a lab-tested 5.24 grams of dried psilocybin mushrooms, containing 28 mg of active psilocybin—just shy of a "heroic dose" benchmarked at 30 mg in clinical studies[1][3]. The experiment featured comprehensive biomarker tracking, including 249 biomarkers via 29 blood vials, brain scans with Kernel technology, and multi-omics profiling to measure DNA, epigenetics, hormones, microbiome activity, and cognitive function[1]. Johnson called it the "most quantified psychedelic experiment in history," aiming to precisely correlate psilocybin’s acute effects with detailed biological and aging metrics, potentially advancing understanding of psychedelic
🔄 Updated: 12/2/2025, 9:40:36 PM
Bryan Johnson conducted a highly technical six-hour livestreamed experiment on March 30, 2025, consuming 5.24 grams of dried psilocybin mushrooms containing 28 mg of lab-confirmed psilocybin, nearly reaching the clinical "heroic" dose of 30 mg[1]. During the session, Johnson tracked 249 biomarkers via 29 blood draws and comprehensive multi-omics profiling—including DNA, epigenetics, hormones, microbiome, and cognitive function—to quantify the psychedelic's effects on biological age and brain activity, using his Kernel brain-imaging helmet and extensive medical supervision[1][3]. This unprecedented data collection aims to methodically analyze psychedelics’ potential to enhance longevity and sensory perception
🔄 Updated: 12/2/2025, 9:50:37 PM
Biohacker Bryan Johnson livestreamed a high-dose psilocybin experiment on X to over one million viewers, consuming 4.67 grams of magic mushrooms (24.9 mg of psilocybin) under medical supervision with a professional facilitator while wearing a brain-scanning helmet from his neurotechnology company Kernel.[1][2][4] Johnson described the experience as profoundly positive, stating "It felt like my consciousness was dialled up to 10/10. I felt hyper aware and alive and insatiably curious," and characterized the psychedelic journey as having "returned my perception to factory settings and dissolved my aged numbness" in his quest to explore
🔄 Updated: 12/2/2025, 10:00:43 PM
American biohacker Bryan Johnson sparked an online frenzy by live-streaming a six-hour experiment in which he consumed 4.67 grams of Psilocybe cubensis magic mushrooms, delivering 24.9 mg of psilocybin, a dose comparable to clinical trials for longevity therapy. Over a million people watched as Johnson, monitored using his Kernel neurotechnology helmet, described the experience as feeling "like my consciousness was dialled up to 10/10" and "hyper aware and alive," aiming to explore psychedelics' potential to extend life by rewiring the brain[1][2][4]. His co-founder Kate Tolo, present during the session, framed the effort as part of a broader project to "make Bryan Johnson
🔄 Updated: 12/2/2025, 10:10:38 PM
Tech entrepreneur Bryan Johnson livestreamed a six-hour experiment ingesting 5.24 grams of dried psilocybin mushrooms containing 28 mg of active psilocybin, a dose just shy of the clinical "heroic" threshold of 30 mg, under strict medical supervision. During the session, Johnson tracked 249 biomarkers via 29 blood draws and extensive tests including brain scans, multi-omics profiling, and cognitive assessments to analyze psychedelics' acute and potential longevity effects on biological aging metrics like telomere length and brain age[2][3]. This represents one of the most quantified psychedelic experiments to date, aiming to scientifically explore psilocybin’s role in neuroplasticity and anti-aging within